Carbamazepine Tablet
Product Images NDC 70518-2242

9 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 70518-2242). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Carbamazepine 200 mg tablet packaging label shows the product name prominently with strength and dosage form. Quantity is 180 tablets. The label includes the NDC 70518-2242-00, manufacturer info (Taro Pharma, Haifa Bay, Israel), and notes repackaging by RemedyRepack Inc. Directions reference the package insert. Storage conditions are included, with warnings to keep medication out of children’s reach.*
FDA Label Image

Carbamazepine 200mg 70518 2242 01

Carbamazepine 200mg 70518 2242 01
Carbamazepine 200 mg tablet bottle label showing a quantity of 100 tablets. The label includes the NDC 70518-2242-01, repackager RemedyRepack Inc., and manufacturer Taro Pharma, Haifa Bay, Israel. Storage instructions and a QR code are also visible.*
FDA Label Image

Carbamazepine 200mg 70518 2242 02

Carbamazepine 200mg 70518 2242 02
Carbamazepine 200 mg tablet label showing a single tablet quantity. The label includes the proprietary name Carbamazepine, strength of 200 mg, and the dosage form as a tablet. It notes that the product is prescription only, repackaged by RemedyRepack Inc., Indiana, PA. The original manufacturer is Taro Pharma, Haifa Bay, Israel.*
FDA Label Image

Carbamazepine 200mg 70518 2242 03

Carbamazepine 200mg 70518 2242 03
Carbamazepine 200 mg oral tablets label shows a 30-count bottle repackaged by RemedyRepack Inc. The label includes the proprietary and generic name, dosage form, strength, quantity, and repackager information. Manufacturer is listed as Taro Pharma, Haifa Bay, Israel. The label also features NDC numbers, storage instructions, and a QR code.*
FDA Label Image

Carbamazepine 200mg 70518 2242 04

Carbamazepine 200mg 70518 2242 04
Carbamazepine 200 mg tablet label showing quantity of 100 tablets. The label includes the brand name 'carBAMazepine' and an indicator that the product is prescription-only (RX ONLY). Manufacturer information states it is repackaged by RemedyRepack Inc., Indiana, PA. The label also includes storage instructions and a QR code for additional product details.*
FDA Label Image

Carbamazepine 200mg 70518 2242 05

Carbamazepine 200mg 70518 2242 05
Label for Carbamazepine 200 mg tablet, quantity of 1, repackaged by RemedyRepack Inc. The label includes the NDC number 70518-2242-05, manufacturer information as Taro Pharma, Haifa Bay, Israel, and storage instructions. It instructs users to see the package insert for directions and indicates the product is prescription only.*
FDA Label Image

Carbamazepine 200mg 70518 2242 06

Carbamazepine 200mg 70518 2242 06
The image shows a drug label for Carbamazepine 200 mg oral tablets. The quantity indicated is 100 tablets. It is repackaged by RemedyRepack Inc. The label includes the NDC number 70518-2242-06, manufacturer information (Taro Pharma, Haifa Bay, Israel), a QR code, and storage directions. The label states 'RX ONLY'.*
FDA Label Image

Carbamazepine 200mg 70518 2242 07

Carbamazepine 200mg 70518 2242 07
Carbamazepine 200 mg oral tablet packaging label showing quantity of 1 tablet. The label includes the brand name Remedy Repack and states RX only. It provides storage directions and repackaging information by RemedyRepack Inc., Indiana, PA. Manufacturer is Taro Pharma, Haifa Bay, Israel.*
FDA Label Image

Chemical Structure (Carbamazepine 01)

Chemical Structure (Carbamazepine 01)
Chemical structure of Carbamazepine, showing a tricyclic ring system with an amide group attached. The structure highlights the molecular framework typical of this active pharmaceutical ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.